Open AccessA platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threats
Author(s) -
Ira M. Longini,
Yang Yang,
Thomas R. Fleming,
César MuñozFontela,
Rui Wang,
Susan S. Ellenberg,
George Qian,
M. Elizabeth Halloran,
Martha Nason,
Victor DeGruttola,
Sabue Mulangu,
Yunda Huang,
Christl A. Donnelly,
Ana-Maria Henao Restrepo
Publication year - 2022
Publication title -
clinical trials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.559
H-Index - 63
eISSN - 1740-7753
pISSN - 1740-7745
DOI - 10.1177/17407745221110880
Subject(s) - medicine , marburg virus , vaccination , vaccine efficacy , clinical trial , vaccine trial , seroconversion , ebola virus , randomized controlled trial , clinical endpoint , infectious disease (medical specialty) , virology , transmission (telecommunications) , disease , outbreak , immunology , virus , computer science , telecommunications